Hostname: page-component-78c5997874-fbnjt Total loading time: 0 Render date: 2024-11-05T08:07:11.125Z Has data issue: false hasContentIssue false

A Perspective on the FDA Premarket Approval Process

Published online by Cambridge University Press:  26 February 2011

John L. Ely*
Affiliation:
Baxter Edwards CVS Division, 17221 Red Hill Avenue, Irvine, California 92714.
Get access

Abstract

Premarket review processes as prescribed by the Medical Device Amendments of 1976 to the Food, Drug, and Cosmetic Act greatly affect the use of materials in medical products, especially for implantable devices. The premarket approval process can have a particularly important role in eventual commercial medical uses of materials. Managing the process properly is often critical to the success or failure of a product.

A review of the law and regulations as they pertain to premarket approval is presented. Subjects included in this overview are prediction of process time and costs, examination of potential pitfalls in the process, recommendations on organizing for successful completion of the process and handling the relationship with FDA.

Specific materials related issues that are likely to arise are noted.

Type
Research Article
Copyright
Copyright © Materials Research Society 1988

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)